U.S. FDA Rejects Eisai’s Aquavan Injection
This article was originally published in PharmAsia News
Executive Summary
Despite a recent advisory panel vote recommending clearance, albeit with strings attached, U.S. FDA has deemed Eisai's Aquavan, a mild-to-moderate sedative for colonoscopies and other procedures, "not approvable.